Carter AC, Chang HY, Church G, Dombkowski A, Ecker JR, Gil E, Giresi PG, Greely H, Greenleaf WJ, Hacohen N, He C, Hill D, Ko J, Kohane I, Kundaje A, Palmer MJ, Snyder MP, Tung J, Urban A, Vidal M, Wong W). Challenges and Recommendations for Epigenomics in Precision Health. Nature Biotechnology. 2017.
Reports & Collections
Kirkpatrick J, Koblentz GD, Palmer MJ, Perello E, Relman DA, Denton SW. Editing Biosecurity: Needs and Strategies for Governing Genome Editing. 2018. (Report, white paper, and edited collected of issue briefs.)
Palmer MJ (Editor). LEAP In Review: A Five Year View of the Synthetic Biology Leadership Excellence Accelerator Program (LEAP). 2017. (Program overview, program evaluation and edited collection of essays from the LEAP program.)
Palmer MJ. Oral Comment on "National Scientific Advisory Board for Biosecurity (NSABB) - September 2015 Meeting on Gain of Function Risk Benefit Analysis". 2015.
Palmer MJ. Written Comment on "Convention on Biological Diversity Technical Working Group on the Risk of Synthetic Biology". 2015.
Kuiken T, Millet P, Oye KA, Palmer MJ. Comment on "US Select Agent Regulations". 2015.
Palmer MJ. Comment on "US Federal Policies for Dual Use Research of Concern". 2013.
You E, Endy D, Palmer MJ. Prospective US National Paper to the Biological Weapons and Toxins Convention. 2012. [Not advanced]
Palmer MJ. Comment on "US BioEconomy Blueprint". 2011.